Atlas Trials

A Pilot Study of Recombinant Human Relaxin (rhRlx) in Compensated Congestive Heart Failure

Clinical trial NCT00259116 · COMPLETED

Trial details

NCT number
NCT00259116
Sponsor
Corthera, Inc.(formerly BAS Medical, Inc.), a member of the Novartis group of companies
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Heart Failure, Congestive
Start date
2005-11-01
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.